Filing Details
- Accession Number:
- 0001401708-19-000170
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-08-08 16:08:52
- Reporting Period:
- 2019-08-06
- Accepted Time:
- 2019-08-08 16:08:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1401708 | Nanostring Technologies Inc | NSTG | Biological Products, (No Disgnostic Substances) (2836) | 200094687 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1432055 | Thomas K Bailey | 530 Fairview Avenue N Seattle WA 98109 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-08-06 | 35,625 | $8.16 | 35,625 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-08-06 | 31,123 | $25.16 | 4,502 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-08-06 | 4,502 | $25.76 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2019-08-06 | 35,625 | $0.00 | 35,625 | $8.16 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 59,375 | 2028-01-15 | No | 4 | M | Direct |
Footnotes
- The sales reported by Mr. Bailey were effected pursuant to a Rule 10b5-1 trading plan adopted on June 14, 2019.
- The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $24.65 to $25.63, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $25.65 to $25.87, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- Twenty-five percent (25%) of the Shares subject to the Option shall vest on the one (1) year anniversary of January 16, 2018 (the "Option Vesting Commencement Date"), and one forty-eighth (1/48th) of the Shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month), subject to the Reporting Person continuing to be a Service Provider through each such date.
Billionaire Hedge Funds
